arrow_back Back Filing freshness 10-Q Q1 FY2026 SEC EDGAR

Personalis, Inc.

PSNL
$14.14 ▲ +1.12 (+8.64%) at close
Healthcare ·Services-Medical Laboratories ·USServices-Medical Laboratories
35 Visible periods
31 Metrics
Peer-ranked Benchmarks
Price Chart
18
Health
Poor
Bearish
auto_awesome

Analytical Summary

Personalis, Inc. faces fundamental challenges with weakness in Return on Common Equity (%) and Profit Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $1.5B
Dividend Yield
Revenue Growth -24.9%
Op. Margin -207.9%
ROIC -12.6%
FCF / Share $-0.25
Trailing P/E
Price / Book 5.8x
FCF Yield
Debt / Equity
info Valuation on last close. End-of-day price, Aug 7, 2026.

35-Year Financial Trajectory

Quarterly
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$15.47M
↓ -24.9%
Net Income Profit after all expenses
$-30.03M
↓ -90.7%
Operating Margin Operating profit as % of sales
-207.9%
↓ -42.7% 1th
FCF / Share Free cash flow per share
$-0.25
↓ -5.3%
trending_up

Bullish Indicators

  • No bullish signals detected.
warning

Bearish Risks

  • Operating Margin (%)Operating Margin (%) is in the bottom quartile
  • Profit Margin (%)Profit Margin (%) is in the bottom quartile
  • Return on Common Equity (%)Return on Common Equity (%) is in the bottom quartile

Health Breakdown

Profitability
2
Returns
23
Financial Health
7
Cash Quality
64

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 10 years · 35 quarters